Kobayashi Pharmaceutical KBYPF Stock
Kobayashi Pharmaceutical Price Chart
Kobayashi Pharmaceutical KBYPF Financial and Trading Overview
| Kobayashi Pharmaceutical stock price | 34.05 USD |
| Previous Close | 34.05 USD |
| Open | 34.05 USD |
| Bid | 34.55 USD x 10000 |
| Ask | 38.99 USD x 10000 |
| Day's Range | 34.05 - 34.05 USD |
| 52 Week Range | 34.05 - 37.43 USD |
| Volume | 1.47K USD |
| Avg. Volume | 0 USD |
| Market Cap | 2.53B USD |
| Beta (5Y Monthly) | 0.259 |
| PE Ratio (TTM) | 109.83871 |
| EPS (TTM) | 0.31 USD |
| Forward Dividend & Yield | 0.67 (1.98%) |
| Ex-Dividend Date | June 29, 2026 |
| 1y Target Est | N/A |
KBYPF Valuation Measures
| Enterprise Value | -61760765952 USD |
| Trailing P/E | 109.83871 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.01517527 |
| Price/Book (mrq) | 1.9008629 |
| Enterprise Value/Revenue | -0.37 |
| Enterprise Value/EBITDA | -2.732 |
Trading Information
Kobayashi Pharmaceutical Stock Price History
| Beta (5Y Monthly) | 0.259 |
| 52-Week Change | -9.030% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 37.43 USD |
| 52 Week Low | 34.05 USD |
| 50-Day Moving Average | 34.05 USD |
| 200-Day Moving Average | 34.84 USD |
KBYPF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 74.34M |
| Float | 36.7M |
| Short Ratio | N/A |
| % Held by Insiders | 30.78% |
| % Held by Institutions | 24.56% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 104 |
| Trailing Annual Dividend Yield | 305.43% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 2.1143 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 1.83% |
| Operating Margin (ttm) | 3.89% |
| Gross Margin | 51.24% |
| EBITDA Margin | 13.55% |
Management Effectiveness
| Return on Assets (ttm) | 3.37% |
| Return on Equity (ttm) | 1.47% |
Income Statement
| Revenue (ttm) | 166.8B USD |
| Revenue Per Share (ttm) | 2243.81 USD |
| Quarterly Revenue Growth (yoy) | 3.20% |
| Gross Profit (ttm) | 85.47B USD |
| EBITDA | 22.6B USD |
| Net Income Avi to Common (ttm) | 3.07B USD |
| Diluted EPS (ttm) | 0.31 |
| Quarterly Earnings Growth (yoy) | -36.19% |
Balance Sheet
| Total Cash (mrq) | 65.03B USD |
| Total Cash Per Share (mrq) | 874.77 USD |
| Total Debt (mrq) | 727M USD |
| Total Debt/Equity (mrq) | 0.35 USD |
| Current Ratio (mrq) | 3.044 |
| Book Value Per Share (mrq) | 17.912916 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Kobayashi Pharmaceutical
| Country | United States |
| State | N/A |
| City | Osaka |
| Address | KDX Kobayashi Doshomachi Building |
| ZIP | 541-0045 |
| Phone | N/A |
| Website | https://www.kobayashi.co.jp |
| Industry | Household & Personal Products |
| Sector(s) | Consumer Defensive |
| Full Time Employees | 3731 |
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Q&A For Kobayashi Pharmaceutical Stock
What is a current KBYPF stock price?
Kobayashi Pharmaceutical KBYPF stock price today per share is 34.05 USD.
How to purchase Kobayashi Pharmaceutical stock?
You can buy KBYPF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kobayashi Pharmaceutical?
The stock symbol or ticker of Kobayashi Pharmaceutical is KBYPF.
Which industry does the Kobayashi Pharmaceutical company belong to?
The Kobayashi Pharmaceutical industry is Household & Personal Products.
How many shares does Kobayashi Pharmaceutical have in circulation?
The max supply of Kobayashi Pharmaceutical shares is 74.34M.
What is Kobayashi Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Kobayashi Pharmaceutical PE Ratio is 109.83871000 now.
What was Kobayashi Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Kobayashi Pharmaceutical EPS is 0.31 USD over the trailing 12 months.
Which sector does the Kobayashi Pharmaceutical company belong to?
The Kobayashi Pharmaceutical sector is Consumer Defensive.